TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 4 | 10 | 17 | 19 | 9 | -15 | -35 | 1 |
| S | %wins | 50 | 75 | 0 | 50 | 75 | 100 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/10 16:34 | 3/12/10 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Mills Mike | AL | O | Principa | S.d | -11 | 7.31 | 3 | -2 | -100 | 0 | D | 137 | 526 | -32 | 11 | 16 | 8 | 5 | 7 | -3 | -3 | 12 | -15 | -28 | -46 |
2/11/10 16:28 | 2/10/10 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Mills Mike | AL | O | Principa | S.d | -36 | 7.05 | 8 | -5 | -100 | 0 | D | 83 | 327 | -19 | -33 | 14 | 4 | 4 | 9 | 0 | -5 | 1 | -2 | -30 | -44 |
7/24/09 16:56 | 7/23/09 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Mills Mike | AL | O | Principa | S.d | -12 | 8.26 | 10 | -2 | -100 | 0 | 17 | -2 | 6 | 1 | -31 | -43 | |||||||||
7/21/09 11:37 | 7/17/09 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Mills Mike | AL | O | Principa | S | -6 | 6.00 | 5 | -1 | -100 | 0 | 27 | 76 | 58 | 52 | 31 | -8 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |